Mostrar el registro sencillo del ítem
dc.contributor.author | Aquino Ordinola, Ruth Elizabeth | |
dc.contributor.author | de Concini, Vidian | |
dc.contributor.author | Dhenain, Marc | |
dc.contributor.author | Lam, Suzanne | |
dc.contributor.author | Gosset, David | |
dc.contributor.author | Baquedano Santana, Laura Estefania | |
dc.contributor.author | Forero, Manuel G | |
dc.contributor.author | Menuet, Arnaud | |
dc.contributor.author | Baril, Patrick | |
dc.contributor.author | Pichon, Chantal | |
dc.date.accessioned | 2023-03-23T15:49:33Z | |
dc.date.available | 2023-03-23T15:49:33Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/13274 | |
dc.description.abstract | Circulating microRNAs (miRNAs) have aroused a lot of interest as reliable blood diagnostic biomarkers of Alzheimer's disease (AD). Here, we investigated the panel of expressed blood miRNAs in response to aggregated Aβ<sub>1-42</sub> peptides infused in the hippocampus of adult rats to mimic events of the early onset of non-familial AD disorder. Aβ<sub>1-42</sub> peptides in the hippocampus led to cognitive impairments associated with an astrogliosis and downregulation of circulating miRNA-146a-5p, -29a-3p, -29c-3p, -125b-5p, and-191-5p. We established the kinetics of expression of selected miRNAs and found differences with those detected in the APP<sub>swe</sub>/PS1<sub>dE9</sub> transgenic mouse model. Of note, miRNA-146a-5p was exclusively dysregulated in the Aβ-induced AD model. The treatment of primary astrocytes with Aβ<sub>1-42</sub> peptides led to miRNA-146a-5p upregulation though the activation of the NF-κB signaling pathway, which in turn downregulated IRAK-1 but not TRAF-6 expression. As a consequence, no induction of IL-1β, IL-6, or TNF-α was detected. Astrocytes treated with a miRNA-146-5p inhibitor rescued IRAK-1 and changed TRAF-6 steady-state levels that correlated with the induction of IL-6, IL-1β, and CXCL1 production, indicating that miRNA-146a-5p operates anti-inflammatory functions through a NF-κB pathway negative feedback loop. Overall, we report a panel of circulating miRNAs that correlated with Aβ<sub>1-42</sub> peptides' presence in the hippocampus and provide mechanistic insights into miRNA-146a-5p biological function in the development of the early stage of sporadic AD. | en_US |
dc.language.iso | eng | |
dc.publisher | MDPI | |
dc.relation.ispartofseries | Cells | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | microRNAs | en_US |
dc.subject | miRNA-146a-5p | en_US |
dc.subject | Alzheimer’s disease | en_US |
dc.subject | Aβ1–42 peptide | en_US |
dc.subject | biomarkers | en_US |
dc.subject | diagnosis | en_US |
dc.subject.mesh | MicroARNs | |
dc.subject.mesh | Enfermedad de Alzheimer | |
dc.subject.mesh | Biomarcadores | |
dc.subject.mesh | Diagnóstico | |
dc.title | Intrahippocampal Inoculation of Aβ1–42 Peptide in Rat as a Model of Alzheimer’s Disease Identified MicroRNA-146a-5p as Blood Marker with Anti-Inflammatory Function in Astrocyte Cells | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.3390/cells12050694 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#1.06.06 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.04 | |
dc.relation.issn | 2073-4409 |
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |